Novanta Stock Forecast, Price & News

-0.20 (-0.16 %)
(As of 06/22/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume49,599 shs
Average Volume100,966 shs
Market Capitalization$4.55 billion
P/E Ratio104.51
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive NOVT News and Ratings via Email

Sign-up to receive the latest news and ratings for Novanta and its competitors with MarketBeat's FREE daily newsletter.

Novanta logo

About Novanta

Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. Its Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products for photonics-based applications, such as industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The company's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless, recorder, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. Its Precision Motion segment offers optical and inductive encoders, precision motors, motion control sub-assemblies, servo drives, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.51 out of 5 stars

Computer And Technology Sector

374th out of 1,591 stocks

Miscellaneous Electrical Machinery, Equipment, & Supplies Industry

8th out of 42 stocks

Analyst Opinion: 1.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Novanta (NASDAQ:NOVT) Frequently Asked Questions

Is Novanta a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Novanta in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Novanta stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NOVT, but not buy additional shares or sell existing shares.
View analyst ratings for Novanta
or view top-rated stocks.

What stocks does MarketBeat like better than Novanta?

Wall Street analysts have given Novanta a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Novanta wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Novanta's next earnings date?

Novanta is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Novanta

How were Novanta's earnings last quarter?

Novanta Inc. (NASDAQ:NOVT) posted its quarterly earnings results on Tuesday, May, 11th. The technology company reported $0.58 EPS for the quarter, beating analysts' consensus estimates of $0.39 by $0.19. The technology company had revenue of $162.60 million for the quarter, compared to the consensus estimate of $156.28 million. Novanta had a trailing twelve-month return on equity of 15.66% and a net margin of 7.34%. The firm's quarterly revenue was up 4.6% on a year-over-year basis. During the same period last year, the business earned $0.51 earnings per share.
View Novanta's earnings history

How has Novanta's stock price been impacted by COVID-19?

Novanta's stock was trading at $79.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NOVT stock has increased by 62.6% and is now trading at $128.55.
View which stocks have been most impacted by COVID-19

What guidance has Novanta issued on next quarter's earnings?

Novanta updated its FY 2021 earnings guidance on Tuesday, June, 8th. The company provided earnings per share guidance of $2.040-2.190 for the period, compared to the Thomson Reuters consensus estimate of $2.110. The company issued revenue guidance of $645 million-655 million, compared to the consensus revenue estimate of $644.35 million.

What price target have analysts set for NOVT?

1 equities research analysts have issued twelve-month price objectives for Novanta's shares. Their forecasts range from $109.00 to $109.00. On average, they anticipate Novanta's stock price to reach $109.00 in the next year. This suggests that the stock has a possible downside of 15.2%.
View analysts' price targets for Novanta
or view top-rated stocks among Wall Street analysts.

Who are Novanta's key executives?

Novanta's management team includes the following people:
  • Mr. Matthijs Glastra, CEO & Chairman (Age 52, Pay $1.12M)
  • Mr. Robert J. Buckley, Chief Financial Officer (Age 47, Pay $649.1k)
  • Mr. Brian S. Young, Chief HR Officer (Age 52, Pay $415.56k)
  • Mr. Peter L. Chang, Corp. Controller & Chief Accounting Officer (Age 56)
  • Ms. Sarah Betadam, Chief Information Officer
  • Ms. Kitty Sahin, Exec. VP of Strategy & Bus. Devel.
  • Mr. Phil Martin, Group Pres of Photonics
  • Ms. Leane Sinicki, Group Pres of Precision Motion
  • Mr. Heinrich Dreyer, Group Pres of Minimally Invasive Surgery
  • Mr. Ray Nash, Corp. Fin. Leader

What is Matthijs Glastra's approval rating as Novanta's CEO?

44 employees have rated Novanta CEO Matthijs Glastra on Matthijs Glastra has an approval rating of 87% among Novanta's employees.

Who are some of Novanta's key competitors?

What other stocks do shareholders of Novanta own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Novanta investors own include NVIDIA (NVDA), Alibaba Group (BABA), Gilead Sciences (GILD), Intuitive Surgical (ISRG), Lam Research (LRCX), Altria Group (MO), AT&T (T), Abiomed (ABMD), Advanced Micro Devices (AMD) and Broadcom (AVGO).

What is Novanta's stock symbol?

Novanta trades on the NASDAQ under the ticker symbol "NOVT."

Who are Novanta's major shareholders?

Novanta's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.46%), Price T Rowe Associates Inc. MD (6.97%), Neuberger Berman Group LLC (5.68%), Alliancebernstein L.P. (4.33%), Artisan Partners Limited Partnership (3.62%) and Conestoga Capital Advisors LLC (3.14%). Company insiders that own Novanta stock include Brian S Young, Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad.
View institutional ownership trends for Novanta

Which major investors are selling Novanta stock?

NOVT stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Price T Rowe Associates Inc. MD, Janus Henderson Group PLC, Arrowstreet Capital Limited Partnership, Alliancebernstein L.P., Northern Trust Corp, Dimensional Fund Advisors LP, and Royal Bank of Canada. Company insiders that have sold Novanta company stock in the last year include Brian S Young, Matthijs Glastra, Peter L Chang, and Robert Buckley.
View insider buying and selling activity for Novanta
or view top insider-selling stocks.

Which major investors are buying Novanta stock?

NOVT stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Capital International Investors, Neuberger Berman Group LLC, Conestoga Capital Advisors LLC, Geode Capital Management LLC, Waddell & Reed Financial Inc., Vident Investment Advisory LLC, and Loomis Sayles & Co. L P.
View insider buying and selling activity for Novanta
or or view top insider-buying stocks.

How do I buy shares of Novanta?

Shares of NOVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novanta's stock price today?

One share of NOVT stock can currently be purchased for approximately $128.55.

How much money does Novanta make?

Novanta has a market capitalization of $4.55 billion and generates $590.62 million in revenue each year. The technology company earns $44.52 million in net income (profit) each year or $1.95 on an earnings per share basis.

How many employees does Novanta have?

Novanta employs 2,200 workers across the globe.

What is Novanta's official website?

The official website for Novanta is

Where are Novanta's headquarters?

Novanta is headquartered at 125 Middlesex Turnpike, Bedford MA, 01730.

How can I contact Novanta?

Novanta's mailing address is 125 Middlesex Turnpike, Bedford MA, 01730. The technology company can be reached via phone at 781-266-5700 or via email at [email protected]

This page was last updated on 6/23/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.